StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.36−0.05 (-3.87%)

Close on Nov 17, 2026Market cap $34.67MP/E –Yield –

Serina Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Serina Therapeutics's market cap was $36.32M on Nov 10, 2026, against $44.91M a year earlier. Over the last 5 years it ranged from $625.82K to $80.61M, with a median of $30.47M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$36.32M+80.1%
2025Dec 31, 2025$20.17M-54.7%
2024Dec 31, 2024$44.55M+204.9%
2023Dec 29, 2023$14.61M-30.2%
2022Dec 30, 2022$20.95M-49.3%
2021Dec 31, 2021$41.35M-27.8%
2020Dec 31, 2020$57.29M-16.4%
2019Dec 31, 2019$68.52M-32.1%
2018Dec 31, 2018$100.91M–

More Serina Therapeutics figures

See a number that looks wrong?